Company Description
UTOpharm(Shanghai) Co., Ltd., founded in 2004 in Shanghai,specialized in development, manufacture and marketing ofpharmaceutical intermediates and APIs. UTOpharm has its ownresearch center and production base. The research center is locatedin Shanghai, owning a strong innovative research and developmentteam with rich experience in organic synthesis area andspecializing in research & development of new products andoptimization of new production process. The production base islocated in Ningbo, Zhejiang province. UTOpharm is equipped with avariety of equipments(1-3000L), including two low-temperaturereaction kettles (500L, -70degree) and one hydrogen reactor (500L,11mPa), which can satisfy a variety of chemical reaction fromsmall-scale tests, pilot experiments and scale up production.Meanwhile,
Utopharm co., ltd is equipped with many analytical devices,such as HPLC and GC. UTOpharm lays great emphasis on thecustomer's demands and regards customer satisfaction as itspriority all the time. Furthermore, UTOpharm is endeavored inestablishing long-term, various, and mutual-benefit cooperationwith companies worldwide. Basic Activities on: Pre-clinicalresearch of generic drugs; Contract research; Contract synthesis;Contract manufacturing; Registration of drugs; Optimization ofsynthesis process Patents situation: Ivabradine HCl: CN101284813B;CN101353325B Ulipristal Acetate: WO2013063859A1; CN201110339479.8;CN201210112043.X